Concord Drugs Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 27/06/2025 ,inter alia, to consider and approve issue of equity shares through ....
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Concord Drugs Limited has informed the BSE that its Board of Directors will meet on Friday, June 27, 2025, at 5:00 PM. The main agenda is to consider and approve raising of funds for business expansion, including through a Preferential Allotment of equity shares or other permissible modes, subject to necessary approvals. The Board will also decide the date, time, and venue for an Extra-Ordinary General Meeting to seek shareholder approval wherever required. No specific amount, pricing, or investor details have been disclosed in this intimation.
If approved, the preferential allotment may result in dilution of existing shareholders' equity. The fund raise, if successful, could support the company's business expansion plans. Investors should wait for the post-board-meeting outcome for pricing and allotment details.